Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹898 Cr.
Stock P/E
-620.6
P/B
1.4
Current Price
₹282.4
Book Value
₹ 202.1
Face Value
10
52W High
₹375
52W Low
₹ 252.5
Dividend Yield
0%

Health X Platform Overview

Business

Health X Platform Ltd. is an Non-Banking Financial Company (NBFC) based in India. Its core business model revolves around providing financial services, primarily credit, to its target market. Given the company name "Health X Platform," it is likely specialized in financing the healthcare sector, which could include lending to hospitals, clinics, medical equipment manufacturers/purchasers, or potentially offering financial products related to healthcare services to consumers via a platform model. The company generates revenue predominantly through interest income from its loan portfolio, as well as fees for various financial services it provides.

Revenue Mix

Specific breakdowns of key business segments and their revenue contributions are not provided. However, based on the company name, potential lending segments could include:

Financing for healthcare infrastructure (e.g., hospital expansion, clinic setup).

Loans for medical equipment procurement.

Working capital finance for healthcare providers and pharmaceutical companies.

Potentially, consumer finance solutions for healthcare procedures or medical expenses, possibly facilitated through a digital platform.

Industry

The Indian NBFC sector is dynamic and highly competitive, characterized by a mix of large diversified players and specialized niche lenders. It acts as a crucial complement to the banking system, often catering to segments or customer profiles that traditional banks find less attractive or harder to serve. Health X Platform Ltd., with its implied focus on the healthcare sector, positions itself as a niche player within this competitive landscape. It likely competes with other specialized NBFCs focused on healthcare finance, as well as dedicated healthcare lending divisions of larger banks and diversified financial institutions. Its "Platform" aspect suggests a potential emphasis on digital distribution and efficient service delivery, aiming to differentiate through technology or specialized domain expertise.

MOAT

Without specific details, potential competitive advantages could include:

Niche Expertise: Deep understanding of the healthcare sector, its specific financial needs, and associated risks, allowing for better credit assessment and tailored product offerings.

Proprietary Platform: A robust, user-friendly, and efficient digital platform for origination, underwriting, and servicing loans could reduce operational costs, enhance customer experience, and enable wider reach.

Strategic Partnerships: Strong relationships with healthcare providers, medical equipment suppliers, or technology partners could provide a consistent deal flow and proprietary market access.

Data & Analytics: Leveraging data from its platform and healthcare sector focus to refine credit models and identify market opportunities.

Growth Drivers

Key factors that could drive growth for Health X Platform Ltd. over the next 3-5 years include:

Growth in the Indian Healthcare Sector: Increasing healthcare expenditure, demand for quality medical services, and government initiatives in healthcare infrastructure will drive demand for financing.

Digital Adoption: Further penetration and acceptance of digital lending platforms in India, allowing for efficient customer acquisition and service.

Underserved Market: Continued existence of healthcare-related financing gaps not fully met by traditional banks.

Expansion of Product Offerings: Introduction of new and innovative financial products catering to evolving needs within the healthcare ecosystem.

Ability to Raise Capital: Access to diverse funding sources at competitive rates to support balance sheet growth.

Risks

Credit Risk: Defaults on loans, particularly if the portfolio is concentrated in specific sub-segments of healthcare or regions, or due to macroeconomic downturns.

Liquidity Risk: Difficulty in accessing timely and cost-effective funding, which is critical for NBFC operations.

Interest Rate Risk: Mismatches between borrowing and lending rates, impacting net interest margins.

Regulatory Risk: Changes in RBI regulations for NBFCs, including capital adequacy norms, asset classification, and provisioning requirements, or specific regulations pertaining to healthcare financing.

Competition: Intense competition from banks, other NBFCs, and emerging FinTech players, potentially leading to margin pressure.

Technology and Cybersecurity Risk: Reliance on a digital platform exposes the company to risks of data breaches, system failures, and cyber-attacks.

Sector-Specific Risks: Policy changes in the healthcare industry, changes in insurance reimbursement models, or advancements in medical technology could impact the financial health of its borrowers.

Management & Ownership

Specific details on Health X Platform Ltd.'s promoters, management team, and ownership structure are not provided. Typically, for Indian NBFCs, strong promoter backing with a clear vision and an experienced management team with expertise in financial services, risk management, and the specific niche (healthcare in this case) are crucial. A well-governed board and diversified ownership structure, including institutional investors, often contribute to stability and growth.

Outlook

The outlook for Health X Platform Ltd. presents a balanced view. On the positive side, the robust growth trajectory of the Indian healthcare sector, coupled with the increasing adoption of digital financial services, provides a significant tailwind. A focused niche strategy, if executed with strong credit underwriting and an efficient digital platform, could allow the company to capture substantial market share within healthcare finance. However, challenges persist. The highly competitive NBFC landscape, the inherent credit risks associated with lending, the need for continuous access to capital, and potential regulatory shifts are significant headwinds. The company's ability to maintain asset quality, innovate its product offerings, and scale its platform while effectively managing operational and technological risks will be critical determinants of its long-term success.

Health X Platform Share Price

Live · BSE / NSE · Inception: 1989
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Health X Platform Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Operating Revenue 307 270 274 281 286 298 301 346 374 447
Other Income 18 28 22 -12 22 25 6 14 14 13
Total Income 325 298 296 269 307 324 307 359 388 460
Total Expenditure 317 273 278 305 311 292 324 356 399 455
Operating Profit 8 25 18 -36 -4 31 -17 3 -11 4
Interest Expense 0 0 0 0 0 0 0 0 0 1
Depreciation 3 2 1 1 1 1 1 2 2 2
Profit Before Tax 5 25 -174 -39 -5 30 -19 1 -15 2
Provision for Tax -29 -25 -23 1 -22 4 -3 1 -2 -0
Profit After Tax 34 50 -151 -40 18 27 -15 0 -13 2
Adjustments -18 -19 41 13 -4 -3 3 1 2 1
Profit After Adjustments 16 31 -109 -27 14 24 -13 1 -11 3
Adjusted Earnings Per Share 5.2 9.8 -34.4 -8.5 4.3 7.5 -4 0.4 -3.5 0.8

Health X Platform Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Operating Revenue 86 133 159 220 385 548 631 1040 1376 1111 1319 1468
Other Income 3 4 3 2 3 3 12 24 60 60 58 47
Total Income 89 137 162 222 389 552 643 1063 1436 1171 1378 1514
Total Expenditure 117 155 174 255 440 561 678 1083 1370 1167 1371 1534
Operating Profit -28 -18 -12 -33 -51 -9 -35 -19 66 4 6 -21
Interest Expense 1 3 1 3 1 3 3 2 1 0 1 1
Depreciation 7 7 6 6 5 4 4 8 9 6 7 7
Profit Before Tax -37 -28 -12 -42 -58 -16 1109 -122 -30 -204 -2 -31
Provision for Tax -0 1 2 1 -5 1 244 -23 -36 -70 -1 -4
Profit After Tax -37 -29 -15 -43 -52 -17 865 -99 6 -134 -1 -26
Adjustments -0 -0 3 5 13 7 -238 27 3 42 3 7
Profit After Adjustments -37 -29 -12 -38 -39 -10 627 -72 9 -91 1 -20
Adjusted Earnings Per Share -11.5 -9 -3.7 -11.8 -12.2 -3.3 197 -22.7 2.8 -28.7 0.4 -6.3

Health X Platform Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 218 195 175 143 210 200 827 753 762 670 641
Minority's Interest 0 0 28 58 36 29 268 240 237 195 124
Borrowings 2 2 0 0 0 0 0 0 0 0 0
Current Liability 31 49 29 25 69 63 70 120 77 98 155
Other Liabilities & Provisions 13 10 6 6 0 0 114 91 73 1 2
Total Liabilities 265 256 238 232 316 293 1278 1204 1149 963 922
Loans 0 0 0 0 0 0 0 0 8 9 9
Investments 9 9 18 22 41 30 513 443 385 265 414
Fixed Assets 126 125 117 116 114 110 93 104 108 100 114
Other Loans 22 13 5 10 10 6 11 15 2 7 10
Other Non Current Assets 19 1 1 1 0 0 120 98 64 17 11
Current Assets 89 108 97 83 151 146 540 541 580 563 361
Total Assets 265 256 238 232 316 293 1278 1204 1149 963 922

Health X Platform Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 7 7 14 12 6 17 12 13 32 31 12
Cash Flow from Operating Activities -12 -2 -49 -30 -69 -31 -207 -112 36 -17 -74
Cash Flow from Investing Activities -1 4 21 -2 -22 21 220 133 -34 -1 171
Cash Flow from Financing Activities 13 5 33 26 103 4 -11 -2 -2 -0 -80
Net Cash Inflow / Outflow -0 7 5 -6 11 -5 1 19 -0 -19 18
Closing Cash & Cash Equivalent 7 14 12 6 17 12 13 32 31 12 30

Health X Platform Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) -11.51 -9 -3.73 -11.81 -12.2 -3.27 197.04 -22.7 2.79 -28.66 0.37
CEPS(Rs) -9.2 -6.81 -2.89 -11.6 -14.85 -3.97 273.26 -28.69 4.71 -40.15 1.62
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 68.52 59.6 55.15 43.23 64.48 61.27 258.25 235.27 238.09 210.58 201.47
Net Profit Margin -42.39 -21.5 -9.24 -19.51 -13.53 -3.12 137.01 -9.57 0.43 -12.02 -0.11
Operating Margin -41.11 -18.84 -7.23 -17.64 -14.56 -2.51 176.24 -11.57 -2.14 -18.31 -0.1
PBT Margin -42.71 -21.04 -7.76 -19 -14.94 -2.99 175.71 -11.76 -2.22 -18.33 -0.18
ROA(%) -12.92 -10.97 -5.96 -18.25 -19.05 -5.62 110.18 -8.02 0.5 -12.64 -0.15
ROE(%) -15.47 -14.02 -8.07 -27.39 -30.43 -8.55 170.23 -12.67 0.78 -18.71 -0.22
ROCE(%) -14.29 -11.07 -5.71 -23.5 -31.37 -6.48 214.79 -15.23 -3.88 -28.4 -0.21
Price/Earnings(x) 0 0 0 0 0 0 1.81 0 108.6 0 706.65
Price/Book(x) 0.94 1.66 2.01 2.77 0.97 1.9 1.38 0.94 1.27 1.15 1.3
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 2.45 2.31 2.21 1.7 0.48 0.67 1.46 0.49 0.67 0.68 0.62
EV/Core EBITDA(x) -7.5 -16.96 -28.2 -11.39 -3.6 -39.61 -26.08 -26.24 13.93 195.23 129.51
Interest Earned Growth(%) 78.39 54.08 19.91 37.9 75.41 42.23 15.18 64.68 32.3 -19.25 18.75
Net Profit Growth -146.59 21.83 48.45 -191 -21.63 67.21 5161.5 -111.5 105.88 -2381.77 98.92
EPS Growth(%) -145.63 21.81 58.5 -216.12 -3.29 73.19 6126.54 -111.52 112.3 -1126.34 101.29
Interest Coverage(x) % -25.73 -8.58 -13.69 -13.01 -38.31 -5.27 333.22 -62.15 -27.52 -694.1 -1.4

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +19% +8% +19% +31%
Operating Profit CAGR +50% — — —
PAT CAGR — — — —
Share Price CAGR -9% -4% -6% +19%
ROE Average 0% -6% +28% +3%
ROCE Average 0% -11% +33% +7%

Health X Platform Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 74.07 %
FII 2.29 %
DII (MF + Insurance) 2.6 %
Public (retail) 21.04 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 73.9273.9273.9273.9474.1174.2474.2474.6974.8474.07
FII 0.560.610.991.711.61.882.042.252.172.29
DII 0.961.351.981.852.062.092.072.072.62.6
Public 24.5624.1223.1122.522.2221.7921.6520.9920.3921.04
Others 0000000000
Total 100100100100100100100100100100

Health X Platform Peer Comparison

Finance - NBFC Edit Columns

Health X Platform Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Health X Platform Pros & Cons

Pros

  • Company is almost debt free.

Cons

  • Company has a low return on equity of -6% over the last 3 years.
  • Debtor days have increased from 18.17 to 21.86days.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp